Therakind is delighted to announce that it has signed a license agreement with Indosys Ltd to develop a product for treating hypoglycaemia.
Hypoglycaemia is a real clinical problem resulting in admittance to hospital and considerable distress for patients and carers. Additionally poor glycaemic control can result in long term health problems.
Dr Nick Boyes commented "We are excited to be working with Therakind in developing such a product utilising our DriDose®. We consider that it has the potential to deliver meaningful benefits to patients and their carers”